Analysts: Altria And Cronos Make A Good Team

Tobacco giant Altria Group Inc. (NYSE: MO) is interested in a buyout of Canadian cannabis company Cronos Group, Inc. (NASDAQ: CRON). Wall Street analysts see Altria and Cronos as a compelling team. Continue reading “Analysts: Altria And Cronos Make A Good Team”

Canopy Growth’s Global Opportunity Could Reach $200B, Benchmark Says In Bullish Initiation

Shares of cannabis and hemp company Canopy Growth Corp. (NYSE: CGC) have doubled since the stock began trading on the New York Stock Exchange back in May. Continue reading “Canopy Growth’s Global Opportunity Could Reach $200B, Benchmark Says In Bullish Initiation”

GW Pharmaceuticals’ FDA Win Reinforces BofA’s Bullish Thesis

The U.S. Food and Drug Administration approval of GW Pharmaceuticals PLC (NASDAQ: GWPH)’s epidiolex therapy for the treatment of seizures was expected — and reinforces the bullish case for owning the stock, according to Bank of America Merrill Lynch. Continue reading “GW Pharmaceuticals’ FDA Win Reinforces BofA’s Bullish Thesis”